Lobbying by Issue

About Lobbying Issues

The Lobbying Disclosure Act defines 79 issue categories that lobbyists must select when filing their quarterly reports. These categories reveal what industries care about most — and where the most money flows to influence policy.

Healthcare (HCR) dominates all other categories, driven by pharmaceutical companies, hospital systems, and insurance giants fighting over drug pricing, Medicare reimbursement, and regulatory policy. Taxation and Budget follow closely, as virtually every industry has a stake in tax policy and government spending decisions.

Click any issue to see top spenders, spending trends, related investigations, and sample lobbying descriptions from actual quarterly filings.

Issue Category Breakdown

The 79 issue codes defined by the Lobbying Disclosure Act cover every major area of federal policy. Whenlobbyists file their quarterly reports, they must select one or more of these codes to describe the subject matter of their advocacy. A single filing can list multiple issue codes, which is common for clients whose interests span several policy areas. The most frequently cited issue codes since 2018, ranked by associated lobbying spending, are: Healthcare/Pharmaceuticals (HCR) at $2.7 billion,Taxation (TAX) at $2.1 billion, Federal Budget & Appropriations (BUD) at $1.9 billion, Defense (DEF) at $1.8 billion, Energy/Nuclear (ENG) at $1.5 billion, Transportation (TRA) at $1.4 billion, Trade (TRD) at $1.2 billion, and Environment/Superfund (ENV) at $1.1 billion. These eight categories alone account for over 60% of all lobbying spending.

Healthcare: The $2.7 Billion Policy Battle

Healthcare has been the most heavily lobbied issue area in every single year since the Lobbying Disclosure Act took effect. The dominance of healthcare lobbying reflects the enormous financial stakes involved: the U.S. healthcare system represents 18% of GDP (roughly $4.8 trillion in 2025), and federal policy decisions on drug pricing, Medicare reimbursement rates, insurance regulations, and FDA approval processes can shift billions of dollars between stakeholders. The pharmaceutical industry alone accounts for a substantial portion of healthcare lobbying, with companies like Pfizer, Johnson & Johnson, Merck, and AbbVie each spending $8–15 million annually, supplemented by PhRMA's $30 million+ annual budget. Hospital systems, health insurers, medical device companies, and patient advocacy groups also maintain major lobbying operations. Key battles in 2025–2026 include Medicare Part D negotiation expansion, biosimilar competition policies, telehealth reimbursement permanence, and AI-assisted diagnostic regulation.

Emerging Issues in 2026: AI, Crypto, and Trade

While traditional policy areas like healthcare and taxation continue to dominate, several emerging issues have rapidly gained lobbying attention in 2025–2026. Artificial intelligence regulation has become one of the fastest-growing lobbying categories, with AI companies, tech giants, and industry groups spending an estimated $185 million in 2025 alone on issues related to AI safety frameworks, liability standards, export controls, and workforce impacts. Companies like OpenAI, Google, Microsoft, Meta, and Anthropic have dramatically expanded their Washington offices, while traditional industries from healthcare to financial services lobby to shape how AI regulations affect their sectors.Cryptocurrency and digital assets represent another surging category, with crypto exchanges, DeFi protocols, and industry associations collectively spending over $75 million annually to influence stablecoin legislation, SEC enforcement policy, and tax treatment of digital assets.

Trade policy has also seen renewed intensity amid ongoing U.S.-China tensions, tariff disputes, and industrial policy legislation. The CHIPS Act implementation, critical minerals supply chain policy, and semiconductor export controls have triggered a wave of lobbying from technology manufacturers, automakers, and energy companies. In 2025, trade-related lobbying spending exceeded $1.4 billion, making it one of the top five issue areas for the first time since 2019. Climate and energy policy continues to generate significant lobbying activity, with the implementation of Inflation Reduction Act tax credits and permitting reform legislation attracting advocacy from both fossil fuel companies and renewable energy developers.

Defense and National Security Lobbying

The defense sector consistently ranks among the top four lobbying issue areas, with $1.8 billion in cumulative spending since 2018. Defense lobbying is dominated by the major prime contractors — Lockheed Martin, Raytheon (RTX), Boeing, Northrop Grumman, and General Dynamics — which each spend $12–18 million annually to influence procurement decisions, authorization bills, and appropriations levels. The annual National Defense Authorization Act (NDAA) process, which sets Pentagon spending priorities, triggers intense lobbying from hundreds of defense clients competing for program funding. Defense lobbyists are disproportionately drawn from the revolving door, with former Pentagon officials, retired generals, and ex-congressional defense committee staff commanding premium rates for their expertise and relationships.

Financial Services and Banking

Financial services lobbying encompasses banking regulation, securities law, insurance policy, consumer finance, and cryptocurrency governance. Major banks like JPMorgan Chase, Bank of America, Citigroup, and Goldman Sachs each maintain lobbying budgets of $6–10 million annually, supplemented by trade associations like the American Bankers Association and the Securities Industry and Financial Markets Association (SIFMA). Key policy fights in 2025–2026 include Basel III capital requirement implementation, SEC climate disclosure rules, Consumer Financial Protection Bureau authority, and the regulatory framework for stablecoins and decentralized finance. Financial services lobbying firms tend to employ former Treasury officials, SEC commissioners, and banking committee staff, reflecting the highly technical nature of financial regulation.

How Issues Connect to the Broader Lobbying Ecosystem

Issue areas don't exist in isolation — they form a web of overlapping policy interests that connectsclients,firms, andlobbyists in complex ways. A single healthcare company might lobby on HCR (healthcare), TAX (taxation), TRD (trade), CPT (computers/technology), and SCI (science) simultaneously, using different lobbyists with expertise in each domain. Understanding which issues attract the most spending helps reveal the policy battles where the most is at stake — and where corporate influence is most concentrated. Each issue page on OpenLobby shows the top spenders, spending trends over time, and the actual lobbying descriptions from quarterly filings, giving you granular insight into exactly what organizations are advocating for.

Understanding Issue Codes

The 79 issue codes used in lobbying disclosures were established by the Senate Office of Public Records and have remained largely unchanged since 1995. Each code uses a three-letter abbreviation (e.g., HCR for Healthcare, TAX for Taxation, DEF for Defense) and covers a broad policy domain. Lobbyists must select at least one code per filing but may select as many as apply. Some codes are highly specific (like TOR for Torts) while others are extremely broad (like GOV for Government Issues). The breadth of some categories can make direct spending comparisons imprecise, but the overall rankings are robust indicators of where lobbying attention is concentrated. OpenLobby enhances the raw filing data by linking issue codes to the specific clients andgeographic patterns driving spending in each area.

Top Issues by Spending in 2026

Healthcare (HCR) remains the most heavily lobbied issue category, with over $2.7 billion in cumulative spending since 2018. The pharmaceutical industry drives much of this spending, as companies lobby on drug pricing legislation, FDA approval pathways, patent protections, and Medicare reimbursement rates. The stakes are enormous: a single regulatory decision can affect billions in pharmaceutical revenue, making healthcare lobbying a perennial priority for some of Washington's largest lobbying clients.

Taxation (TAX) ranks second at over $2.1 billion, driven by ongoing debates over corporate tax rates, international tax structures, and individual tax provisions set to expire under the 2017 Tax Cuts and Jobs Act. Defense (DEF) follows at $1.8 billion, with spending concentrated around appropriations cycles and weapons system procurement decisions. The technology sector has pushed Computers/Information Technology (CPT) into the top five, reflecting Silicon Valley's dramatic expansion of its Washington lobbying operations.

Emerging Issues: AI, Crypto, and Trade Policy

The most dynamic growth in 2026 lobbying has been in issue areas connected to emerging technology. Filings mentioning artificial intelligence have surged dramatically, with our AI lobbying analysisdocumenting a multi-fold increase in AI-related lobbying activity since 2023. Companies from OpenAI to Lockheed Martin now include AI provisions in their lobbying filings, spanning issues from algorithmic transparency to military AI applications.

Cryptocurrency and digital asset lobbying has similarly exploded as Congress considers comprehensive digital asset legislation. Trade policy (TRD) has resurged as a top lobbying category amidtariff and trade disruptions, with manufacturers, retailers, and agricultural exporters all escalating their Washington presence. These shifts demonstrate how lobbying spending serves as a real-time barometer of corporate America's policy anxieties.

Issue Arms Races: When Opposing Sides Escalate

Some of Washington's most expensive lobbying battles occur when industry groups on opposite sides of an issue escalate spending simultaneously. Our issue arms race analysis identifies policy domains where competing interests have created spending spirals. Healthcare offers the clearest example: pharmaceutical manufacturers lobby against price controls while insurance companies and hospital systems lobby for reforms that would shift costs away from payers. Both sides spend tens of millions quarterly, creating a policy stalemate that favors the status quo.

Energy policy exhibits similar dynamics, with fossil fuel companies and renewable energy advocates competing for legislative attention. Defense spending battles pit contractors against fiscal hawks, while technology regulation pits Big Tech companies against consumer advocacy groups. These arms races make lobbying one of the most reliable indicators of which policy issues are most contested in Congress.

How Issues Map to Government Agencies

Lobbying filings also disclose which government agencies and congressional chambers were contacted. This creates a two-dimensional picture of influence: what issue was lobbied, and who was lobbied. Healthcare filings overwhelmingly target HHS, CMS, and the Senate Finance Committee. Defense filings target the Pentagon, Armed Services Committees, and Appropriations subcommittees. Technology filings increasingly target the FTC, FCC, NIST, and the Senate Commerce Committee.

By combining issue-level and agency-level data, OpenLobby provides a comprehensive map of where corporate influence is directed. Visit any issue page to see the full breakdown of agencies contacted, top spending clients, quarterly trends, and the actual lobbying descriptions from filed reports. For comparative analysis across issue areas, try our industry comparison tool or explore issue battles for head-to-head spending matchups.

Seasonal Patterns in Issue Lobbying

Lobbying activity on specific issues follows predictable seasonal rhythms tied to the congressional calendar. Budget and appropriations issues (BUD) spike during the fall, when Congress negotiates spending bills. Tax issues (TAX) surge around major tax legislation deadlines and expiration dates. Defense spending lobbying peaks during the National Defense Authorization Act (NDAA) markup cycle, typically in late spring and summer. Our seasonal lobbying analysischarts these patterns across all 79 issue categories, revealing when different industries concentrate their Washington influence efforts.

Understanding these cycles is valuable for researchers, journalists, and policymakers tracking corporate influence. A spike in healthcare lobbying during a particular quarter may simply reflect the annual Medicare payment rulemaking cycle rather than a new policy battle. Conversely, unexpected surges in lobbying on issues like trade (TRD) or computers/technology (CPT) often signal emerging legislative threats that haven't yet made headlines. OpenLobby's real-time tracking ofrecent filings helps identify these early signals.

The Multi-Issue Strategy

Sophisticated lobbying clients rarely limit themselves to a single issue category. A major pharmaceutical company might simultaneously lobby on healthcare reform (HCR), taxation (TAX), trade (TRD), intellectual property (CPT), and science/technology (SCI). This multi-issue approach reflects the interconnected nature of policy: a drug pricing bill might involve healthcare regulation, tax incentives for R&D, international trade agreements affecting generic imports, and patent law provisions.

The number of issue categories per filing has increased steadily over the past decade, suggesting that organizations view policy battles as increasingly interconnected. In 2018, the average filing listed 2.8 issue codes; by 2026, that figure has risen to 3.4. This expansion reflects both growing regulatory complexity and more strategic lobbying approaches that connect multiple policy levers to achieve business objectives. The text analysis of lobbying descriptions reveals the specific bills and provisions being targeted within each issue category.

Tracking Issue Trends Over Time

OpenLobby's trends analysis tracks how spending on each issue category evolves year over year. Some issues show remarkable consistency: healthcare (HCR) and taxation (TAX) have been the top two lobbying categories in every year since 2018. Others show dramatic shifts: trade (TRD) lobbying surged during tariff disputes, declined during trade stability, and has surged again in 2026. Technology-related categories have shown the strongest growth trajectory, rising from middle-of-the-pack to top-five status as AI,cryptocurrency, and data privacy have become dominant policy concerns.

The rise and fall of issue categories tells the story of American policy priorities. Energy (FUE, ENV) lobbying reflects the ongoing tension between fossil fuel interests and climate policy. Financial services (BNK, FIN) lobbying tracks regulatory cycles from Dodd-Frank implementation through fintech disruption. Immigration (IMM) and labor (LBR) lobbying responds to workforce policy debates. Each issue page on OpenLobby provides year-by-year spending breakdowns and top client rankings, giving you the data to trace these policy narratives through the lens of lobbying expenditures. For the latest quarterly data, see our2026 statistics overview.

Under-Lobbied Issues: Policy Gaps and Blind Spots

Not all important policy areas attract proportionate lobbying attention. Issues like consumer protection (CSP), arts and humanities (ART), and disaster planning (DIS) receive minimal lobbying spending despite their significance to millions of Americans. This spending gap highlights a structural reality of the lobbying system: policy areas with concentrated corporate interests attract far more lobbying resources than those with diffuse public benefits. The result is that heavily lobbied issues receive disproportionate legislative attention, while under-funded policy areas may languish without sustained advocacy.

Some advocates argue that this imbalance is precisely what makes lobbying disclosure so important. By making spending data transparent, OpenLobby enables citizens, journalists, and policymakers to see which interests are most aggressively pursuing their policy goals — and which are not. Understanding the issue landscape is the first step toward ensuring that legislative priorities reflect public needs rather than just corporate spending power.

Issue Data Methodology

Issue spending figures on OpenLobby represent the total lobbying expenditures associated with filings that selected each issue code. Because a single filing can list multiple issue codes, the same spending amount may be counted under several issues. This means that summing all issue-level spending would exceed total lobbying spending — the overlap reflects the multi-issue nature of modern lobbying engagements. Each issue page provides the raw filing counts and unique client counts alongside spending totals to give a more complete picture.

All data is sourced from LD-2 quarterly lobbying disclosure filings submitted to the U.S. Senate Office of Public Records. OpenLobby processes and indexes these filings to create the searchable, cross-referenced issue database available here. For bulk data downloads, visit our data downloads page. For details on how we process and normalize filing data, see our methodology documentation.

Explore the Full Lobbying Ecosystem

Issues are one dimension of OpenLobby's comprehensive lobbying database. To understand who is driving spending in each issue area, explore our clients directory, firms rankings, and lobbyist profiles. For geographic patterns, see lobbying by state. For the latest aggregate numbers, visit our 2026 statistics overview or browse all investigationsfor narrative analyses of the trends shaping Washington's influence industry. Whether you're a journalist investigating corporate influence, a researcher studying policy dynamics, or a citizen wanting to understand how lobbying shapes the laws that affect your life, OpenLobby's issue data provides the foundation for informed analysis.